Shut down the FDA’s failed GLP-1 green list
People taking GLP-1 drugs deserve to know exactly what is being injected into their bodies. A new Food and Drug Administration warning letter shows why they may not. The FDA warned Harbin Jixianglong Biotech, a Chinese manufacturer tied to GLP-1 active pharmaceutical ingredients, over serious manufacturing and labeling violations. Most alarming, the company was placed […]




